Alpha 2.0
Login Register
» Authors » Karen E Bremner

Karen E Bremner

Explore the profile of Karen E Bremner including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 781
Followers 0
Related Specialties
Oncology
General Medicine
Public Health
Top 10 Co-Authors
Murray D Krahn
George Tomlinson
Claire de Oliveira
Murray Krahn
William W L Wong
Nicholas Mitsakakis
Shabbir M H Alibhai
Gary Naglie
Jeffrey S Hoch
Jordan J Feld
Published In
Med Decis Making
CMAJ Open
Qual Life Res
Value Health
PLoS One
Affiliations
Soon will be listed here.
Recent Articles
1.
Understanding the Growing Burden of Malignant Pleural Effusion - Epidemiology, Healthcare Utilization, and Cost: A Canadian Perspective
Czarnecka-Kujawa K, Krahn M, Wu F, Stanbrook M, Tomlinson G, Yasufuku K, et al.
Respiration . 2025 Jan; :1-13. PMID: 39837310
Introduction: Malignant pleural effusion (MPE) is common in advanced malignancy. Data are needed on healthcare utilization and costs. Methods: This population-based retrospective cohort study included patients aged ≥18 years with...
2.
A scoping review to create a framework for the steps in developing condition-specific preference-based instruments de novo or from an existing non-preference-based instrument: use of item response theory or Rasch analysis
Tsui T, Torres S, Bielecki J, Mitsakakis N, Trudeau M, Bremner K, et al.
Health Qual Life Outcomes . 2024 May; 22(1):38. PMID: 38745165
Background: There is no widely accepted framework to guide the development of condition-specific preference-based instruments (CSPBIs) that includes both de novo and from existing non-preference-based instruments. The purpose of this...
3.
Home-based versus supervised group exercise in men with prostate cancer on androgen deprivation therapy: A randomized controlled trial and economic analysis
Alibhai S, Papadopoulos E, Santa Mina D, Ritvo P, Tomlinson G, Sabiston C, et al.
J Geriatr Oncol . 2023 Nov; 15(1):101646. PMID: 37976654
Introduction: Differences between health outcomes, participation/adoption, and cost-effectiveness of home-based (HOME) interventions and supervised group-based training (GROUP) in men with prostate cancer (PC) on androgen deprivation therapy (ADT) are currently...
4.
The impact of the early COVID-19 pandemic on healthcare system resource use and costs in two provinces in Canada: An interrupted time series analysis
Zeitouny S, Cheung D, Bremner K, Pataky R, Pequeno P, Matelski J, et al.
PLoS One . 2023 Sep; 18(9):e0290646. PMID: 37682823
Introduction: The aim of our study was to assess the initial impact of COVID-19 on total publicly-funded direct healthcare costs and health services use in two Canadian provinces, Ontario and...
5.
Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study
Mendlowitz A, Bremner K, Krahn M, Walker J, Wong W, Sander B, et al.
CMAJ . 2023 Apr; 195(14):E499-E512. PMID: 37040993
Background: As First Nations Peoples are a priority focus of Canada's commitment to eliminating hepatitis C virus (HCV) as a public health threat, understanding individuals' progression from diagnosis to cure...
6.
Disparities in health utilities among hepatitis C patients receiving care in different settings
Saeed Y, Mason K, Mitsakakis N, Feld J, Bremner K, Phoon A, et al.
Can Liver J . 2023 Mar; 6(1):24-38. PMID: 36908577
Although chronic hepatitis C (CHC) disproportionately affects marginalized individuals, most health utility studies are conducted in hospital settings which are difficult for marginalized patients to access. We compared health utilities...
7.
Lessons from First Nations partnerships in hepatitis C research and the co-creation of knowledge
Mendlowitz A, Bremner K, Feld J, Jones L, Hill E, Antone E, et al.
Can Liver J . 2023 Mar; 6(1):46-55. PMID: 36908573
Administrative health data provide a rich and powerful tool for health services research. Partnership between researchers and the Ontario First Nations HIV/AIDS Education Circle (OFNHAEC) allowed for comprehensive analyses of...
8.
Impact of direct-acting antiviral treatment on health utility in patients with chronic hepatitis C in hospital and community settings
Wong W, Wong J, Bremner K, Saeed Y, Mason K, Phoon A, et al.
Liver Int . 2023 Jan; 43(4):805-818. PMID: 36606706
Background: Direct-acting antiviral agents (DAAs) have transformed chronic hepatitis C (CHC) treatment. Continued affordable access to DAAs requires updated cost-effectiveness analyses (CEA). Utility is a preference-based measure of health-related quality...
9.
Initial health care costs for COVID-19 in British Columbia and Ontario, Canada: an interprovincial population-based cohort study
Tsui T, Zeitouny S, Bremner K, Cheung D, Mulder C, Croxford R, et al.
CMAJ Open . 2022 Sep; 10(3):E818-E830. PMID: 36126976
Background: COVID-19 imposed substantial health and economic burdens. Comprehensive population-based estimates of health care costs for COVID-19 are essential for planning and policy evaluation. We estimated publicly funded health care...
10.
"Bring the Hoses to Where the Fire Is!": Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs
Cheung D, Bremner K, Tsui T, Croxford R, Lapointe-Shaw L, Del Giudice L, et al.
Value Health . 2022 May; 25(8):1307-1316. PMID: 35527165
Objectives: Local health leaders and the Director General of the World Health Organization alike have observed that COVID-19 "does not discriminate." Nevertheless, the disproportionate representation of people of low socioeconomic...